Jie Cheng (Jason) CHANG

• Promote Iclusig (ponatinib) and Busulfex (busulfan) in the hematology field.
• Conduct clinical discussions with hematologists and oncologists to drive prescription growth.
• Build relationships with KOLs and support brand initiatives through medical education.

• Promote Latuda to healthcare professionals in psychiatric divisions at 2 medical centers and 7 regional hospitals.
• Conduct product presentations, share scientific data, and address inquiries regarding Latuda’s usage.
• Build and maintain relationships to increase prescription rates and support effective use in treating psychosis.
Achievements:
• Achieved 125% YTD target and 31% sales growth in 2023 compared to 2022.
• Successfully listed Latuda in MOHW-TPH & TPECH, achieving 150% YTD target in MOHW-TPH.
• Managed CHANTO project to enhance brand recognition.

• Wholesale distribution and marketing of marine fuel.
• Develop new business opportunities for marine fuel at Marubeni’s bunker ports.
Achievements:
• Achieved a 38% annual sales growth in 2021.
• Secured a long-term marine fuel contract with Yang Ming Marine Transportation.
• Contributed to a biodiesel energy innovation project aimed at reducing carbon emissions.
• General Secretary of the Welfare Committee (Jan 2019 - Mar 2021), organizing company events with high employee satisfaction.

• Researched marine biogeochemical cycling processes of trace metals in phytoplankton.
• Managed laboratory supplies and assisted in data analysis and paper writing.